Bausch Health Companies Bhc Q2 2018 Earnings Conference Call Transcript | Latest News RSS feed

Bausch Health Companies Bhc Q2 2018 Earnings Conference Call Transcript - Latest News


Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Cantor Global Healthcare Conference 2018 (Transcript)

Bausch Health Companies Inc. (NYSE:BHC) Company Conference Presentation October 1, 2018 3:30 PM ET Executives ... what I said in the call and maybe a little bit more since I have learned more since ... read more

30th Annual Piper Jaffray Healthcare Conference

... Papa on Q3 2018 Results - Earnings Call Transcript ┬╗ Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Cantor Global Healthcare Conference 2018 (Transcript) ┬╗ Bausch Health Companies Inc ... read more

EYEPOINT PHARMACEUTICALS INC (EYPT) Q2 2019 Earnings Conference Call Transcript

My name is Amanda, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharma's Fiscal Period Ended December 31st, 2018 Financial Results ... read more

Looking for another news?


Kala Pharmaceuticals, Inc. (KALA) Q1 2019 Earnings Call Transcript

And welcome to Kala Pharmaceuticals first quarter 2019 earnings conference call ... fourth quarter of 2018 for the 2020 Medicare coverage cycle. We continue to make progress working through those bids ... read more


Bausch Health Companies Inc. (BHC) Management Presents at Evercore ISI HealthconX Conference (Transcript)

Bausch Health Companies Inc. (NYSE:BHC) Evercore ISI HealthconX Conference Call November 28, 2018 3:30 PM ET Executives Paul Herendeen ... we expect revenue to go back to a level similar to what we ... read more

BHC and Teva: How Free Cash Flow and Net Debt Stack Up

In its fourth-quarter earnings conference call, Bausch Health Companies (BHC) has highlighted its Bausch + Lomb/International segment and Salix segment as the key growth drivers for the company in ... read more

PDL BioPharma Inc. (PDLI) Q4 2018 Earnings Conference Call Transcript

Welcome to the PDL BioPharma Quarterly Conference Call ... Bausch Health adding an authorized generic of Glumetza. Additional decreases include the decline in royalties from the Queen et al. patents ... read more

FPRX Advances FIGHT, SIGA Secures BARDA Contract, TRVN Faces FDA Panel In Oct.

Earlier this quarter, the Company secured contracts to service approximately 1,400 new beds. The Company now expects to service approximately 31,000 beds by the end of 2018 ... subsidiaries of Bausch ... read more

Bausch (BHC) Resubmits NDA for Duobrii for Plaque Psoriasis

Bausch Health Companies Inc.'s BHC dermatology division ... However, the dermatology market continues to be challenging. Gilead's earnings per share estimates have increased from $6.11 to $6.57 for ... read more

Bausch Health: Strong Cash Flow Trends in Fiscal 2018

Bausch Health (BHC) reported less than $25 billion total debt on its balance sheet as of November 6, almost $7.4 billion lower than that reported by the company in the first ... to report its ... read more

Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)

27, 2018 (GLOBE NEWSWIRE ... specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and its parent company, Bausch Health Companies Inc. ... read more

PDL BioPharma Inc. (PDLI) Q4 2018 Earnings Conference Call Transcript

PDL BioPharma Inc. (NASDAQ: PDLI) Q4 2018 Earnings Conference Call March 14, 2019 ... it included some one-time gains and an increase in the fair value associated with Bausch Health adding an ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us